IndraLab

Statements


USP11 activates hepatic tumorigenesis. 1 / 1
| 1

eidos
"Collectively , these findings suggest that USP11 , as KLF4-binding partner , is an important mediator of hepatic tumorigenesis that functions via degradation of KLF4 and is a potential treatment target for liver diseases ."